Latest news with #MYND
Gizmodo
5 days ago
- Gizmodo
This Ultra-Repairable Bluetooth Speaker Addresses the Ugliest Part of Consumer Tech
Right to repair is a big deal lately, and there are plenty of new products that prove it. One of the best examples in the tech world is Framework, which has grown immensely by centering modularity and repairability in the ethos of its laptops and new mini desktop PC. And like any gadget trend worth its weight in lithium-ion, other hardware companies are taking note and hopping on the repairability bandwagon. I'm elated to say that this headwind of modularity has now been extended to the world of audio. This Bluetooth speaker from Teufel, a German audio company whose name translates in English to 'devil' or 'demon,' is anything but evil, in my very secular opinion. The reason I say that is because it actually bothers to tackle the concept of repairability and modularity. According to Teufel, its new speaker, called Mynd, is fully repairable, including the battery, which is often the first component in gadgets of this variety to fail. And when the battery goes, so does the power, and when there's no power, well… that's when things wind up in landfills. It's not just the battery, though. Teufel's Mynd speaker also has open-source software and hardware, which means that you can actually print some components at home with a 3D printer or create new drivers for the speaker. Theoretically, you don't even have to buy the Mynd from Teufel to own one. Instead, if you have a 3D printer and some technical know-how, you can print the shell, use Teufel's software, and buy the components you want. After that, just assemble them correctly, and there you go; you have a Mynd. 'A 3D printer with enough print volume and materials could print all the plastic parts, and we also have published the software the MYND uses internally. That means it needs only a handful of screws and you could build your very own speaker. You can also adjust the acoustic tuning to your personal wishes,' said an engineer for Teufel in a blog post. I love repairability: it's better for the Earth and it's better for people, which are two very important things. That being said, I do have some skepticism about how Mynd sounds, since there are constraints in making something that is almost entirely open-source and modular. One of those things is the speaker grate, which, as the engineers of Mynd state, had to be made of plastic. It's hard to say how that affects the sound without trying one. If there's one real problem with Mynd, it's that Teufel doesn't appear to be shipping it to the U.S. at the moment. If you're in Europe, though, you can order this speaker for €229.99 through Teufel's site. It's worth noting that Teufel does ship speakers to the U.S. with Fender branding, so maybe that restriction will change in the future. The fact of the matter is that people want products that will last and also products they can feel good about. Most people—myself included—have that pang of guilt when something goes wrong with a gadget and you have to trash it, and it's especially demoralizing when you know that things just don't have to be this way. Given the choice, I think most of us would just opt to buy a new battery over an entirely new speaker. Teufel might be demonic by name, but from what I'm seeing, the Mynd feels pretty saint-like.
Yahoo
25-03-2025
- Business
- Yahoo
Management Cease Trade Order Status Report
Vancouver, British Columbia--(Newsfile Corp. - March 24, 2025) - MYND Life Sciences Inc. (CSE: MYND) ("MYND" or the "Company") announced on March 3, 2025, the Company was granted a management cease trade order (MCTO) under the National Policy 12-203 of the Canadian Securities Administrators ("NP 12-203") imposed against certain insiders of the Company. The MCTO was granted as the Company had been advised by its external auditors (the "Auditors") that they will not be in a position to complete their work on the Company's annual consolidated financial statements for the year ended October 31, 2024 (the "2024 Financial Statements") prior to the filing deadline of February 28, 2025 (the "Annual Filing Deadline"), due to a delay in finalizing the required financial documents due to significant restructuring of the Company's debt and equity. As a result, the Company will not be able to file the 2024 Financial Statements, accompanying Management Discussion & Analysis and CEO and CFO certifications, and the Annual Information Form (collectively, the "2024 Annual Filings") prior to the Annual Filing Deadline as required under applicable Canadian securities laws. The Company has made arrangements to complete and file the 2024 Financial Statements prior to the April 29, 2025 deadline. Accordingly, subsequent to the Annual Filing Deadline, the Company will be in default of its continuous disclosure obligations under applicable Canadian securities laws and placed on the defaulting issuers list of the British Columbia Securities Commission ("BCSC"). In accordance with the alternative information guidelines set out in National Policy 12-203- Management Cease Trade Orders ("NP 12-203") MYND is giving the following update: On March 1, 2025, the Company announced that it applied for a management cease trade order ("MCTO") with the applicable securities regulatory authorities in Canada on the basis that the Company would be unable to file its Annual Audited Financial Statement, the Required Filing, for the year ended October 31, 2024 by the applicable filing deadlines. The MCTO was issued on March 1, 2025 and restricts all trading in securities of the Company, whether direct or indirect, by the Chief Executive Officer and Chief Financial Officer of the Company. The MCTO does not affect the ability of other shareholders of the Company to trade their securities. The Company's management continues to work diligently to complete the Required Filing and anticipates that the Required Filing will be filed by April 29, 2025. The Company confirms that since the date of the Original Announcement: (i) other than as described above, there has been no material change to the information set out in the Original Announcement that has not been generally disclosed; (ii) there has been no failure by the Company in fulfilling its stated intentions with respect to satisfying the provisions of the alternative information guidelines set out in NP 12-203; (iii) there has not been any other specified default by the Company under NP 12-203; and (iv) there is no other material information concerning the affairs of the Company that has not been generally disclosed. The Company will make further announcements with respect to the status of the 2024 Annual Filings as and when appropriate. ABOUT MYND LIFE SCIENCES INC. MYND Life Sciences Inc. is a medical biotech drug research and development company focused on neuro-pharmaceutical and novel psilocybin drug development, and diagnostics. MYND is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by unique molecular concepts for the applications of Psilocybins for overcoming disease. The Company advances pharmaceutical developments through rigorous science and clinical trials while diligently patenting and safeguarding its intellectual property. Contact:Dr. Lyle Oberg, MD, Executive ChairEmail: ir@ To view the source version of this press release, please visit Sign in to access your portfolio
